A Study of Nivolumab Combined With Ipilimumab and Nivolumab Alone in Patients With Advanced or Metastatic Solid Tumors of High Tumor Mutational Burden (TMB-H)
Clinical trial NCT03668119 · COMPLETED
Trial details
- NCT number
- NCT03668119
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-10-31
- Primary completion
- 2022-05-03
- Enrollment
- 212
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.